Efficacy and safety of drug-eluting stents in long-term follow-up.
作者信息
Miura Shin-Ichiro, Kawamura Akira, Saku Keijiro
出版信息
Intern Med. 2008;47(11):987-8. doi: 10.2169/internalmedicine.47.1126. Epub 2008 Jun 2.
Abstract
摘要
相似文献
1
Efficacy and safety of drug-eluting stents in long-term follow-up.
Intern Med. 2008;47(11):987-8. doi: 10.2169/internalmedicine.47.1126. Epub 2008 Jun 2.
2
Temporal course of neointimal formation after drug-eluting stent placement: is our understanding of restenosis changing?药物洗脱支架置入后新生内膜形成的时间进程：我们对再狭窄的理解正在改变吗？
JACC Cardiovasc Interv. 2009 Apr;2(4):300-2. doi: 10.1016/j.jcin.2009.01.004.
3
Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.紫杉醇洗脱球囊后扩张与依维莫司洗脱支架治疗裸金属支架：使用光学相干断层成像术在 6 个月随访时的前瞻性随机研究。
Circ Cardiovasc Interv. 2014 Dec;7(6):760-7. doi: 10.1161/CIRCINTERVENTIONS.113.001146. Epub 2014 Nov 4.
4
Comparison of zotarolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for coronary revascularization: the ZEST (comparison of the efficacy and safety of zotarolimus-eluting stent with sirolimus-eluting and paclitaxel-eluting stent for coronary lesions) randomized trial.比较冠状动脉血运重建中使用佐他莫司洗脱支架与西罗莫司和紫杉醇洗脱支架的疗效：ZEST（佐他莫司洗脱支架与西罗莫司洗脱及紫杉醇洗脱支架治疗冠状动脉病变的疗效和安全性比较）随机试验。
J Am Coll Cardiol. 2010 Oct 5;56(15):1187-95. doi: 10.1016/j.jacc.2010.03.086.
5
Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.裸金属支架置入术后基于导管的紫杉醇给药与药物洗脱支架在冠状动脉疾病支架内再狭窄高危患者中的比较。
Cardiovasc Revasc Med. 2017 Dec;18(8):596-600. doi: 10.1016/j.carrev.2017.05.018. Epub 2017 May 31.
6
The wound healing response after implantation of a drug-eluting stent is impaired persistently in the long term.药物洗脱支架植入后的伤口愈合反应长期持续受损。
Heart Vessels. 2016 Jun;31(6):985-9. doi: 10.1007/s00380-015-0676-y. Epub 2015 May 5.
7
Crush stenting with paclitaxel-eluting or sirolimus-eluting stents for the treatment of coronary bifurcation lesions.使用紫杉醇洗脱支架或西罗莫司洗脱支架进行挤压式支架置入术治疗冠状动脉分叉病变。
Angiology. 2008 Aug-Sep;59(4):475-83. doi: 10.1177/0003319707312519. Epub 2008 Apr 2.
8
Acute and long-term outcomes of ostial stentings among bare-metal stents, sirolimus-eluting stents, and paclitaxel-eluting stents.裸金属支架、西罗莫司洗脱支架和紫杉醇洗脱支架开口处支架置入的急性和长期预后
Coron Artery Dis. 2013 May;24(3):224-30. doi: 10.1097/MCA.0b013e32835c8fce.
9
Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents.西罗莫司或紫杉醇洗脱支架冠状动脉植入术后再狭窄的预测因素。
Circulation. 2006 May 16;113(19):2293-300. doi: 10.1161/CIRCULATIONAHA.105.601823. Epub 2006 May 8.
10
Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.西罗莫司洗脱支架与紫杉醇洗脱支架治疗冠状动脉初发病变的随机对照试验：REALITY试验
JAMA. 2006 Feb 22;295(8):895-904. doi: 10.1001/jama.295.8.895.
Zotero 插件